Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 251 entries
View as:

Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00665366 Org: User:
Start: 06/30/08 End: 10/31/11 Due: 10/31/12

Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)

Phase: N/A Priority: Normal
NCT ID: NCT04186403 Org: User:
Start: 01/13/20 End: 09/22/21 Due: 09/22/22

Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT03238326 Org: User:
Start: 08/23/17 End: 08/05/25 Due: 08/05/26

"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT00201994 Org: User:
Start: 11/30/03 End: 07/31/05 Due: 07/31/06

Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01981811 Org: User:
Start: 03/31/14 End: 12/31/14 Due: 12/31/15

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Phase: N/A Priority: Normal
NCT ID: NCT00332241 Org: User:
Start: 06/30/06 End: 04/30/08 Due: 04/30/09

Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00857818 Org: User:
Start: 04/30/09 End: 03/31/10 Due: 03/31/11

PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00948090 Org: User:
Start: 01/31/10 End: 06/30/13 Due: 06/30/14

Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01396421 Org: User:
Start: 07/31/11 End: 01/31/14 Due: 01/31/15

A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03538691 Org: User:
Start: 07/13/18 End: 07/29/22 Due: 07/29/23

A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging

Phase: N/A Priority: Normal
NCT ID: NCT04038957 Org: User:
Start: 08/07/19 End: 06/06/23 Due: 06/06/24

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT01509053 Org: User:
Start: 01/31/12 End: 10/31/12 Due: 10/31/13

A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02174822 Org: User:
Start: 01/31/14 End: 04/30/14 Due: 04/30/15

Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT01424670 Org: User:
Start: 09/02/11 End: 07/04/16 Due: 07/04/17

Effect on Cognitive Function of a Treatment With Aripiprazole

Phase: N/A Priority: Normal
NCT ID: NCT00329810 Org: User:
Start: 03/31/05 End: 03/31/06 Due: 03/31/07

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00132886 Org: User:
Start: 12/31/04 End: 12/31/06 Due: 12/31/07

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT01702181 Org: User:
Start: 08/31/12 End: 12/31/13 Due: 12/31/14

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT02013531 Org: User:
Start: 11/30/13 End: 06/30/14 Due: 06/30/15

Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity

Phase: N/A Priority: Normal
NCT ID: NCT02194933 Org: User:
Start: 02/28/15 End: 04/30/16 Due: 04/30/17

8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase: N/A Priority: Normal
NCT ID: NCT01451827 Org: User:
Start: 10/31/11 End: 07/31/13 Due: 07/31/14

A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)

Phase: N/A Priority: Normal
NCT ID: NCT00685360 Org: User:
Start: 05/08/08 End: 06/11/10 Due: 06/11/11

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT01922258 Org: User:
Start: 09/30/13 End: 03/31/17 Due: 03/31/18

Aripiprazole and Lexapro Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT00361790 Org: User:
Start: 08/31/06 End: 11/30/06 Due: 11/30/07

A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00300846 Org: User:
Start: 12/31/05 End: 07/31/07 Due: 07/31/08

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04174365 Org: User:
Start: 10/30/19 End: 09/07/22 Due: 09/07/23